Hide

FocusBar

Subscribe to Premium Member
Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M72,342Revenue $M123,133Net Margin (%)3.1Z-Score4.4
Enterprise Value $M80,790EPS $3.2Operating Margin %5.9F-Score7
P/E(ttm))18.2Cash Flow Per Share $4.1Pre-tax Margin (%)5.1Higher ROA y-yY
Price/Book1.910-y EBITDA Growth Rate %19.9Quick Ratio0.7Cash flow > EarningsY
Price/Sales0.65-y EBITDA Growth Rate %8.0Current Ratio1.4Lower Leverage y-yN
Price/Cash Flow11.4y-y EBITDA Growth Rate %22.5ROA % (ttm)5.9Higher Current Ratio y-yY
Dividend Yield %1.3Insider Buy (3m)0ROE % (ttm)10.3Less Shares Outstanding y-yN
Payout Ratio %30.0Shares Outstanding M1,231ROI % (ttm)8.8Gross Margin Increase y-yY

Gurus Latest Trades with CVS

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Number of guru portfolios checked: 51.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CVSVanguard Health Care Fund 2013-03-31 Add0.3%$48.35 - $55.3
($51.98)
$ 58.713%Add 466.6%1,699,800
CVSWallace Weitz 2013-03-31 Reduce-0.58%$48.35 - $55.3
($51.98)
$ 58.713%Reduce -32.31%557,700
CVSJohn Hussman 2013-03-31 Sold Out -0.32%$48.35 - $55.3
($51.98)
$ 58.713%Sold Out0
CVSRay Dalio 2013-03-31 Reduce-0.13%$48.35 - $55.3
($51.98)
$ 58.713%Reduce -44.46%340,450
CVSJoel Greenblatt 2013-03-31 Reduce-0.07%$48.35 - $55.3
($51.98)
$ 58.713%Reduce -30.68%60,144
CVSJames Barrow 2013-03-31 Reduce-0.02%$48.35 - $55.3
($51.98)
$ 58.713%Reduce -27%686,895
CVSScott Black 2012-12-31 Buy 1.2%$44.7 - $49.24
($46.99)
$ 58.725%New holding, 172675 sh.172,675
CVSRay Dalio 2012-12-31 Add0.27%$44.7 - $49.24
($46.99)
$ 58.725%Add 1001.51%612,946
CVSJoel Greenblatt 2012-12-31 Add0.14%$44.7 - $49.24
($46.99)
$ 58.725%Add 141.96%86,763
CVSJohn Hussman 2012-12-31 Reduce-0.9%$44.7 - $49.24
($46.99)
$ 58.725%Reduce -75%250,000
CVSLeon Cooperman 2012-12-31 Sold Out -0.05%$44.7 - $49.24
($46.99)
$ 58.725%Sold Out0
CVSJohn Hussman 2012-09-30 Buy 1.2%$43.99 - $48.59
($46.2)
$ 58.727%New holding, 1000000 sh.1,000,000
CVSRay Dalio 2012-09-30 Buy 0.04%$43.99 - $48.59
($46.2)
$ 58.727%New holding, 55646 sh.55,646
CVSLeon Cooperman 2012-09-30 Reduce-0.57%$43.99 - $48.59
($46.2)
$ 58.727%Reduce -90.62%56,000
CVSJames Barrow 2012-09-30 Reduce-0.51%$43.99 - $48.59
($46.2)
$ 58.727%Reduce -84.27%984,300
CVSWarren Buffett 2012-09-30 Sold Out -0.33%$43.99 - $48.59
($46.2)
$ 58.727%Sold Out0
CVSPRIMECAP Management 2012-09-30 Reduce-0.04%$43.99 - $48.59
($46.2)
$ 58.727%Reduce -96.13%21,000
CVSJoel Greenblatt 2012-06-30 Add0.05%$43.14 - $46.49
($44.87)
$ 58.731%Add 56.43%37,199
CVSLee Ainslie 2012-06-30 Sold Out -3.1%$43.14 - $46.49
($44.87)
$ 58.731%Sold Out0
CVSLeon Cooperman 2012-06-30 Reduce-1.16%$43.14 - $46.49
($44.87)
$ 58.731%Reduce -68.42%596,955
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CVS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
CVS Vanguard Health Care Fund 2013-03-311,699,8000.140.37+466.6%
CVS Mario Gabelli 2013-03-311,633,6620.130.57+3.13%
CVS Scott Black 2013-03-31173,5330.011.2+0.5%
CVS PRIMECAP Management 2013-03-3121,00000
CVS Ruane Cunniff 2013-03-3126,15500.01-0.38%
CVS James Barrow 2013-03-31686,8950.060.07-27%
CVS Joel Greenblatt 2013-03-3160,14400.17-30.68%
CVS Wallace Weitz 2013-03-31557,7000.051.2-32.31%
CVS Ray Dalio 2013-03-31340,4500.030.17-44.46%
CVS John Hussman 2013-03-31000Sold Out
CVS Scott Black 2012-12-31172,6750.011.2New Buy
Premium Most recent portfolio changes are included for Premium Members only!


CVS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Finucane Anne A.Director 2013-04-15Sell500$57.242.55view
Brennan Troyen AEVP, Chief Medical Officer 2013-04-15Sell139,618$57.312.43view
Brennan Troyen AEVP, Chief Medical Officer 2013-03-19Sell34,422$548.7view
PICCOLO C ADirector 2012-12-14Sell98,555$49.1719.38view
Sussman AndrewSVP & President, MinuteClinic 2012-10-04Sell9,020$4919.8view
Bisaccia LisaSVP, Chief HR Officer 2012-10-01Sell56,493$48.4221.23view
Moriarty Thomas MEVP & General Counsel 2012-10-01Buy6,164$48.6720.61view
Joyner J. DavidEVP, Sales & Account Services 2012-09-19Sell33,903$4822.29view
Finucane Anne A.Director 2012-09-17Sell1,000$46.8725.24view
Denton David MEVP, CFO 2012-09-13Sell11,526$4724.89view

Press Releases about CVS:

Quarterly/Annual Reports about CVS:

News about CVS:

Articles On GuruFocus.com
Walgreen Co. (WAG) Dividend Stock Analysis Apr 05 2013 
Chris Davis' Davis New York Venure Fund 2013 Annual Commentary Mar 08 2013 
Early Movers for Feb. 6, 2013 Feb 06 2013 
Delphi Management's Scott Black Releases Fourth Quarter New Stocks Jan 31 2013 
Dividend Contenders in Value for the Accumulation or Income Distribution Phase of the Retirement Por Jan 30 2013 
Steven Romick’s Top Growth Predictable Stocks Jan 22 2013 
My 4 Favorites from the 20 Most Recommended Dividend Stocks at All-Time Highs Jan 19 2013 
My 3 Favorites from the 20 Best Recommended Services Dividend Stocks Jan 12 2013 
Why Is Leon Cooperman Shopping in Walgreen’s? Dec 16 2012 
Tesco to Close or Sell U.S. Stores; Will Warren Buffett Buy More? Dec 05 2012 

More From Our Partners
Stock Market News for May 21, 2013 - Market News May 21 2013 - ZACKS

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK